TARA ▼ -0.4% - Protara Therapeutics, Inc. $TARA - Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support 15-OCT-2026 08:00 AM ET